Rapture
Jump to navigation
Jump to search
A highly addictive drug whose patent is owned by Alchemax. The initial experience is described as pleasant drowsiness. Chemical dependency sets in almost immediately. Withdrawal damages the myelin sheathes around pain-transmitting neurons. The combination of pain compliance and chemical dependency can only be treated by aggressive neurological gene therapy therapies.
